Intraperitoneal AAV9-shRNA inhibits target expression in neonatal skeletal and cardiac muscles

Biochemical and Biophysical Research Communications

Volumn 405, Issue 2, 2011, Pages 204-209

  Mayra, Azat ^a   Tomimitsu, Hiroyuki ^a   Kubodera, Takayuki ^a   Kobayashi, Masaki ^a   Piao, Wenying ^a   Sunaga, Fumiko ^a   Hirai, Yukihiko ^b   Shimada, Takashi ^b   Mizusawa, Hidehiro ^a   Yokota, Takanori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

AAV9; Neonatal; ShRNA

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; COPPER ZINC SUPEROXIDE DISMUTASE; CREATINE KINASE; LACTATE DEHYDROGENASE; PARVOVIRUS VECTOR; PROTEIN; SHORT HAIRPIN RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DIVISION; CELL STRAIN HEK293; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; GENE SILENCING; GENE TARGETING; HEART MUSCLE; HUMAN; HUMAN CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER; LIVER DYSFUNCTION; MOUSE; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKELETAL MUSCLE; VIRAL GENE THERAPY;

ANIMALS; DEPENDOVIRUS; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HUMANS; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED ICR; MUSCLE, SKELETAL; MYOCARDIUM; RNA INTERFERENCE; RNA, SMALL INTERFERING; SUPEROXIDE DISMUTASE;

EID: 79651473395     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.009     Document Type: Article

References (23)

1. Rossi J.J. Expression strategies for short hairpin RNA interference triggers. Hum. Gene Ther. 2008, 19:313-317.
2. Gao X., Zhang P. Transgenic RNA interference in mice. Physiology 2007, 22:161-166.
3. Saito Y., Yokota T., Mitani T., Ito K., Anzai M., Miyagishi M., Taira K., Mizusawa H. Transgenic small interfering RNA halts amyotrophic lateral sclerosis in a mouse model. J. Biol. Chem. 2005, 52:42826-42830.
4. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., Kay M.A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006, 25:537-541.
5. Magee T.R., Artaza J.N., Ferrni M.G., Vermet D., Zuniga F.I., Cantini L., Reisz-Porszasz S., Rajfer J., Gonzalez-Cadavidm N.F. Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass. J. Gene Med. 2006, 8:1171-1181.
6. Louboutin J.P., Wang L., Wilson J.M. Gene transfer into skeletal muscle using novel AAV serotypes. J. Gene Med. 2005, 7:442-451.
7. Zincarelli C., Soltys S., Rengo G., Rabinowitz J.E. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 2008, 16:1073-1080.
8. Blankinship M.J., Gregorevic P., Allen J.M., Harper S.Q., Harper H., Halbert C.L., Miller A.D., Chamberlain J.S. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol. Ther. 2004, 10:671-678.
9. Wang Z., Zhu T., Qiao C., Zhou L., Wang B., Zhang J., Chen C., Li J., Xiao X. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 2005, 23:321-328.
10. Yue Y., Ghosh A., Long C., Bostick B., Smith B.F., Komegay J.N., Duan D.A. A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol. Ther. 2008, 16:1944-1952.
11. Inagaki K., Fuess S., Strom T.A., Gibson G.A., Mctiernan C.F., Kay M.A., Nakai H. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol. Ther. 2006, 14:45-53.
12. Towne C., Raoul C., Schneider B.L., Aebischer P. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. Mol. Ther. 2008, 16:1018-1025.
13. Ogura T., Mizukami H., Mimuro J., Madoiwa S., Okada T., Matsushita T., Urabe M., Kume A., Hamada H., Yoshikawa H., Sakata Y., Ozawa K. Utility of intraperitoneal administration as a route of AAV serotype 5 vector-mediated neonatal gene transfer. J. Gene Med. 2006, 8:990-997.
14. Foust K.D., Poirier A., Pacak C.A., Mandel R.J., Flotte T.R. Neonatal intraperitoneal or intravenous injection of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neurons. Hum. Gene Ther. 2008, 19:61-70.
15. Bostick B., Ghosh A., Yue Y., Long C., Duan D. Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Ther. 2007, 14:1605-1609.
16. Foust K.D., Nurre E., Montgomery C.L., Hemandez A., Chen C.M., Kaspar B.K. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 2009, 27:59-65.
17. Yokota T., Miyagishi M., Hino T., Matsumura R., Tasinato A., Urushitani M., Rao R.V., Takahashi R., Bredesen D.E., Taira K., Mizusawa H. SiRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzyme. Biochem. Biophys. Res. Commun. 2004, 314:283-291.
18. Hermens W.T., Ter Brake O., Dijkhuizen P.A., Sonnemans M.A., Grimm D., Kleinschmidt J.A., Verhaagen J. Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in nervous system. Hum. Gene Ther. 1999, 10:1885-1891.
19. Pacak C.A., Conlon T., Mah C.S., Byme B.J. Relative persistence of AAV serotype 1 vector genomes in dystrophic muscle. Genet. Vaccines Ther. 2008, 6:14.
20. Schwarzkopf M., Knobeloch K.P., Rohde E., Hinderlich S., Wiechens N., Lucka L., Horak I., Reutter W., Horstkorte R. Sialylation is essential for early development in mice. Proc. Natl. Acad. Sci. USA 2002, 99:5267-5270.
21. Malicdan M.C., Noguchi S., Nonaka I., Hayashi Y., Nishino I. A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum. Mol. Genet. 2007, 16:2669-2682.
22. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
23. Manno C.S., Pierce G.F., Arruda V.R., Glader B., Ragni M., Rasko J.J., Ozelo M.C., Hoots K., Blatt P., Konkle B., Dake M., Kaye R., Razavi M., Zajko A., Zehnder J., Rustagi P.K., Nakai H., Chew A., Leonard D., Wright J.F., Lessard R.R., Sommer J.M., Tigges M., Sabatino D., Luk A., Jiang H., Mingozzi F., Couto L., Ertl H.C., High K.A., Kay M.A. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 2006, 12:342-347.